Kumar V, Panda BK. CAN COST OF PHARMACOLOGICAL THROMBOLYTIC THERAPY BE A MEDICATION MANAGEMENT STRATEGY FOR ACUTE CORONARY SYNDROME?. Asian J Pharm Clin Res [Internet]. 2017 Mar. 1 [cited 2025 Feb. 2];10(3):363-6. Available from: https://mail.innovareacademics.in/journals/index.php/ajpcr/article/view/16308